Trevena, Inc. (NASDAQ: TRVN) today announced that NASDAQ has halted trading of the Company’s common stock.The U.S. Food and Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Hot FDA News Management Comments Trading Halts

Trevena (TRVN) Confirms FDA Panel Voted 8 Against and 7 in Favor of Approval of OliceridineOctober 11, 2018 5:05 PM Trevena Stock Trading Halted; FDA Advisory Committee to Review Oliceridine for the Treatment of Moderate to Severe Acute PainOctober 11, 2018 7:00 AM Trevena (TRVN) Halted, News PendingOctober 11, 2018 6:55 AM Trevena (TRVN): JMP Securities Continues to See AdComm Vote in Favor of OliceridineOctober 10, 2018 9:40 AM Jefferies Downgrades Trevena (TRVN) to HoldOctober 10, 2018 6:01 AM Pre-Open Movers 10/09: (PYX) (PEIX) (PZZA) Higher; (TRVN) (AFMD) (BLKB) Lower (more...)October 9, 2018 9:30 AM Trevena (TRVN) Declines After FDA Posts Briefing Documents for OliceridineOctober 9, 2018 8:21 AM